SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $579,553 | +1.1% | 4,781 | -4.5% | 0.27% | +2.3% |
Q2 2023 | $573,173 | -46.1% | 5,005 | -35.1% | 0.26% | -69.7% |
Q1 2023 | $1,063,083 | +6.4% | 7,713 | 0.0% | 0.87% | +46.0% |
Q4 2022 | $999,451 | +12.9% | 7,713 | -3.7% | 0.59% | +17.4% |
Q3 2022 | $885,000 | +23.3% | 8,009 | -16.4% | 0.50% | +16.6% |
Q2 2022 | $718,000 | -18.8% | 9,581 | -15.3% | 0.43% | -23.0% |
Q1 2022 | $884,000 | -8.5% | 11,310 | +99.6% | 0.56% | -8.9% |
Q4 2020 | $966,000 | +134.5% | 5,667 | +120.5% | 0.62% | +80.9% |
Q2 2020 | $412,000 | – | 2,570 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |